Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS5822193B2 - Novel microorganism - Google Patents
[go: Go Back, main page]

JPS5822193B2 - Novel microorganism - Google Patents

Novel microorganism

Info

Publication number
JPS5822193B2
JPS5822193B2 JP14512481A JP14512481A JPS5822193B2 JP S5822193 B2 JPS5822193 B2 JP S5822193B2 JP 14512481 A JP14512481 A JP 14512481A JP 14512481 A JP14512481 A JP 14512481A JP S5822193 B2 JPS5822193 B2 JP S5822193B2
Authority
JP
Japan
Prior art keywords
culture
medium
stachybotrys
properties
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP14512481A
Other languages
Japanese (ja)
Other versions
JPS5783281A (en
Inventor
井沢武年
貝瀬洋次
宮崎和成
篠原正直
大城靖男
中野善正
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP14512481A priority Critical patent/JPS5822193B2/en
Publication of JPS5783281A publication Critical patent/JPS5783281A/en
Publication of JPS5822193B2 publication Critical patent/JPS5822193B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】 本発明はスタキボトリス属に属する新規な微生物に関す
る。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel microorganism belonging to the genus Stachybotrys.

本発明に係る微生物は以下に述べる通り新菌種であり、
本発明者らは之をスタキボトリス エスピー、T−78
9と命名する。
The microorganism according to the present invention is a new bacterial species as described below,
The inventors have identified Stachybotrys sp., T-78.
Name it 9.

■ 採集地 徳島県鳴門市の土壌より分離した。■ Collection area Isolated from soil in Naruto City, Tokushima Prefecture.

■ 各種培養上の性状 スタキポトリス エスピー・T−789 不完全菌T−789株の肉眼的および顕微鏡的観察(第
1図に示す)に基く各種培地上における培養の特徴は次
に記載する通りである。
■Characteristics on various cultures Stachypotrys sp. T-789 The characteristics of culturing Stachypotrys sp. T-789 on various media based on macroscopic and microscopic observations (shown in Figure 1) are as follows. .

A 肉眼的観察 1)麦芽エキス寒天培地 生育はきわめて遅く27℃、30日間培 養で17〜20mm。A. Macroscopic observation 1) Malt extract agar medium Growth is extremely slow and cultured at 27℃ for 30 days. 17-20mm in length.

集落の周辺部は波状に生育し限局的である。The area around the village grows in waves and is localized.

集落は中央部が凸状の隆起を示し周辺部に放射状の摺曲
を生じる。
The center of the village shows a convex bulge, and the periphery shows radial sliding.

空中菌糸は薄く全面に着生し、培養初期の白色から次第
に胞子形成がおこり中央部ではモール(Mo l e
、1 )の色調を呈して密生するが、周辺部にかけては
輪状に胞子形成が見られる。
Aerial hyphae are thin and epiphytic over the entire surface, and spore formation gradually occurs from white at the initial stage of culture, and in the center, spore formation occurs.
, 1), and grows densely, but sporulation can be seen in a ring around the periphery.

裏面はコークタン(CorkTan、 4 i e )
The back side is Cork Tan (4ie)
.

拡散性色素は豊富でアンバー(Amber 、 31e
)。
Diffusible pigments are abundant and amber (Amber, 31e
).

2)ツアペック寒天培地 生育は良好で27℃、30日間の培養で 45龍に生育。2) Czapek agar medium Growth was good and after culturing at 27℃ for 30 days. Grows into 45 dragons.

集落は中心凸状で放射状の摺曲を形成し、周辺部は波状
の生育を示す。
The colony has a convex center and a radial curve, and the periphery shows wavy growth.

中心凸状部から外側に同心円状に薄く白色の空中菌糸を
着生し、胞子形成は周辺部にのみ同心円状に生じ、凸状
部は菌糸の溶解した状態となりきわめて湿潤である。
Thin, white aerial mycelium grows concentrically outward from the central convex part, and spore formation occurs concentrically only at the periphery, and the convex part is extremely moist with dissolved hyphae.

裏面はマスタードブラウン(Mustard Brown、 2pi )。The back side is mustard brown. Brown, 2pi).

拡散性色素は産生じない。■ 生理学的性質 好気性の菌で次に示す生理学的性質を有する。No diffusible pigments are produced. ■ Physiological properties It is an aerobic bacterium with the following physiological properties.

pH温度 生育しうる条件 3.5〜11.5 15〜38°C最
適生育条件 4.5〜10.5 20〜32℃■ 形
態学的性質 第1図から以下のことが明らかである。
pH Temperature Conditions for growth 3.5-11.5 15-38°C Optimum growth conditions 4.5-10.5 20-32°C Morphological properties The following is clear from Figure 1.

即ち各種培地上で菌核およびその他の有性性殖器管は確
認されず、梗子胞子型の無性胞子形成が観察された。
That is, no sclerotia or other sexual reproductive organs were observed on the various media, and asexual sporulation of the ascospore type was observed.

菌糸は多種の培地上で形成され、複雑に分枝し2〜4μ
の菌糸幅で縦横に伸長している。
Hyphae are formed on a variety of media, are intricately branched, and have a diameter of 2 to 4 μm.
The hyphae extend horizontally and vertically with a width of .

梗子柄は菌糸から単純分枝をなしく1個の梗子柄からの
他の梗子柄への分校はなし)基部の足細胞から3〜4個
の隔壁を有して、直立もしくはゆるいわん曲をなして伸
長する。
The pedicel has simple branches from the hyphae, and there is no branching from one pedicle to other pedicles) It has 3 to 4 septa from the podocyte at the base, and is either erect or gently curved. and expand.

梗子柄の菌糸幅は基部で4.3〜4.7μ、中央部で3
.6〜4.5μ。
The hyphae width of the pedicel is 4.3-4.7μ at the base and 3μ at the center.
.. 6-4.5μ.

梗子柄の先端はわずかに膨らみその頂部から大きさ7.
9〜9.3X3.6〜4,7μの楕円形〜徳利型の梗子
が3〜7個直立して形成される。
The tip of the pedicel is slightly swollen and the size is 7.5mm from the top.
Three to seven elliptical to bottle-shaped stalks, measuring 9 to 9.3 x 3.6 to 4.7 microns, are formed upright.

梗子は平滑で無色〜薄黄褐色を呈する。The stalks are smooth and colorless to pale yellowish brown.

梗子胞子は梗子の先端から求基的に連結して生じ直鎖は
作らず半月状の小塊となりその数7〜26個。
The mycospores are produced by basophilically connecting from the tips of the sycamores and do not form straight chains, but instead form semi-moon-shaped clusters of 7 to 26 pieces.

梗子柄は大きさ4.9〜8.OX3.3〜4.7μの亜
球型〜卵形でありその表面は粗面〜イボ状。
The pedicel is 4.9-8. It is subglobular to ovoid with an OX of 3.3 to 4.7μ, and its surface is rough to warty.

又その色調はダークアイブイ(D、k Ivy 、
24po )〜灰黒色を呈する。
Also, the color tone is dark eye buoy (D, k Ivy,
24po) to exhibit a gray-black color.

梗子胞子塊は粘性物による被膜は観察されない。No coating of viscous material was observed on the mycospore mass.

上記の菌学的性質を有する本菌の分類学上の位置を検束
便覧「ザ ジエネラ オブ ハイフオミセテス フロム
ソイル(The Genera ofHyphomy
cetes From 5oil、TheWillia
ms &Wilkins CompanyVoltim
ore 、 G、L、Barron 、 1968年
)」および[ア マニュアル オブ ソイル フンジャ
イ(A MANUAL OF SO’IL F
UNGI、。
The taxonomic position of this bacterium, which has the above mycological properties, was determined in the handbook ``The Genera of Hyphomycetes from Soil''.
cetes From 5oil, TheWilliam
ms & Wilkins CompanyVoltim
ore, G.L., Barron, 1968) and [A MANUAL OF SO'IL F.
UNGI,.

The Iowa 5tate University
PressAmes I owa USA 、 J
、 C、Gi 1man。
The Iowa University
Press Ames Iowa USA, J
, C, Gi 1man.

1971年)」および「ザ ジエネラ オブ フンジャ
イ スポルレーチング イン ピュア カルチャー(T
he Genera of FungiSporola
ting −in Pure Cu1ture、VER
AG VON J 。
1971)” and “The Genera of Hungjai Sporating in Pure Culture (T.
he Genera of Fungi Sporola
ting -in Pure Culture, VER
AG VON J.

CREMER3301LEHRE、J、A、VONAR
X、1970年)」等により検索すると本菌はサツカル
ド(5accardo)の分類系式に従うとハイフオミ
セテス網デマチャケア工科スタキボト。
CREMER3301LEHRE, J, A, VONAR
X, 1970), etc., this bacterium is classified as Hyphomycetes network Demachacarea, according to the classification system of Satucardo (5accardo).

リス属に属する。Belongs to the genus Squirrel.

即ち子のう果その他の有性性殖器管を有せず、梗子から
暗褐色の梗子胞子を生じ、かつ又生じた梗子胞子が梗子
の頂端に半月上に集まる性状を有する本菌株の性状はス
タキボトリス属の性状と一致する。
That is, the characteristics of this strain have the property that it does not have asci or other sexual reproductive organs, produces dark brown inchospores from the inflorescence, and that the produced inchospores gather in a half-moon shape at the apex of the inflorescence. The characteristics match those of the genus Stachybotrys.

本菌の諸性状を上記検索便覧およびビスビーG、R(1
943):Trans。
The properties of this bacterium can be found in the above search guide and Bisbee G, R (1
943): Trans.

Br1t Mycol、soc、、 26 : 133
−143、ズツク RK (1946) : Myco
logia、38 :69−76、バロンG、L(19
61)、(::an。
Br1t Mycol, soc, 26: 133
-143, Zutsuku RK (1946): Myco
Logia, 38:69-76, Baron G, L (19
61), (::an.

J、Bot、、39:153−157等の文献並びにI
FO保存保存標準比較同定したところスタキボトリス
ロブラタ(S tac、hybot−r、ys・Iob
ulata IFO5369)が最も類似すると判定さ
れた。
J. Bot, 39:153-157, and I
FO preservation preservation standard comparison Identified Stachybotrys
Lobrata (S tac, hypot-r, ys・Iob
ulata IFO5369) was determined to be the most similar.

しかしスタキボトリスロブラタは梗子柄が1mTILに
も達するものがありかつ又本菌株が単純分枝をなすのに
対し1つの梗子株から更に梗子株が分枝伸長する性質を
有する点が異なる。
However, Stachybotrys lobulata differs in that some of the inflorescences reach up to 1 mTIL, and unlike the present strain, which forms simple branches, the inflorescences of Stachybotrys lobulata have the property of branching and elongating from one inflorescence to another.

また本菌株はツアペック寒天培地で良好な梗子胞子形成
が認められるが、スタキボトリスロブラタはツアペック
寒天培地での梗子胞子の形成はほとんど認められない培
養上の相違を有する。
In addition, this strain is found to form good inchospores on Czapek's agar medium, whereas Stachybotrythrobrata has a culture difference in that almost no inchospore formation is observed on Czapek's agar medium.

又本菌株は至適生育範囲がpH4,5〜10.5に広く
存在する点においても、上記株とは相違している。
This strain also differs from the above-mentioned strains in that its optimal growth range is broadly from pH 4.5 to 10.5.

従って以上の理由から、本菌株を新菌種と認めスタキボ
トリス エスピー、T−789と命名した。
Therefore, for the above reasons, this bacterial strain was recognized as a new bacterial species and named Stachybotrys sp. T-789.

同色の表示記載は[カラー ハーモニー マニュアル(
Col for Harmony Manual 。
Display descriptions of the same color can be found in [Color Harmony Manual (
Col for Harmony Manual.

1958年、Container Corporati
on ofAmerica)jの表示法に従った。
1958, Container Corporation
on of America).

上記した新菌株スタキボトリス エスピー。The above-mentioned new strain Stachybotrys sp.

T−789は微工研に受託番号微工研菌寄第3802号
(FERM−P 3802)として受託された。
T-789 was entrusted to FERM-P3802 with accession number FERM-P 3802.

上記スタキボトリス属に属する本発明の微生物は、之を
培養することによって培養液中に、下記代印で表わされ
る新規な化合物を産出する。
When the microorganism of the present invention belonging to the genus Stachybotrys is cultured, it produces a novel compound represented by the symbol below in the culture solution.

上記式〔■〕で表わされる化合物は、6,7−ジヒドロ
キシ−2,5,5,8a−テトラメチル−12,3,4
,4a、5,6,7,8,8a−デカヒドロナフタレン
−1−スピロ−27(6/、7/−ジホルミル−47−
ヒドロキシ−27,3/−ジヒドロベンゾフラン)と命
名される。
The compound represented by the above formula [■] is 6,7-dihydroxy-2,5,5,8a-tetramethyl-12,3,4
,4a,5,6,7,8,8a-decahydronaphthalene-1-spiro-27(6/,7/-diformyl-47-
Hydroxy-27,3/-dihydrobenzofuran).

これは抗補体活性作用を有し、自己免疫疾患、腎炎、リ
ュウマチ、膠原病等の治療薬として有用なものである。
It has an anti-complement activity and is useful as a therapeutic agent for autoimmune diseases, nephritis, rheumatism, collagen diseases, etc.

本発明微生物による上記構造式CI、lで表わされる化
合物の収得方法は、具体的には次の如くして実施される
Specifically, the method for obtaining the compound represented by the structural formula CI, 1 using the microorganism of the present invention is carried out as follows.

即ちまず上記微生物を通常の栄養物及び添加物を含有す
る培地で培養する。
That is, the microorganism is first cultured in a medium containing conventional nutrients and additives.

培養基として一般に用いられる窒素源としては、例えば
大豆粉、大豆油、コーンスチツプリカー、酵母エキス。
Nitrogen sources commonly used as culture media include, for example, soybean flour, soybean oil, corn steep liquor, and yeast extract.

乾燥酵母、オートミール、肉エキス、カゼイン加水分解
物、アンモニウム塩、硝酸塩等を例示でき炭素源として
は、例えばブドウ糖、グリセリン、麦芽糖、デンプン、
乳糖、ショ糖、糖蜜等を例示できる。
Examples include dry yeast, oatmeal, meat extract, casein hydrolyzate, ammonium salts, nitrates, etc. Carbon sources include, for example, glucose, glycerin, maltose, starch,
Examples include lactose, sucrose, and molasses.

また培地に添加される添加物としては例えば炭酸カルシ
ウム、塩化ナトリウム、硫酸マグネシウム、リン酸等の
無機塩を例示でき、更に該培地には必要に応じて鉄、銅
、マンガン、亜鉛等の金属の塩を微量含有していてもよ
い。
In addition, examples of additives added to the medium include inorganic salts such as calcium carbonate, sodium chloride, magnesium sulfate, and phosphoric acid, and metals such as iron, copper, manganese, and zinc may be added to the medium as necessary. It may contain a small amount of salt.

培養は、上記培養基を含有する通常の水性培地で、表面
培養でも深部通気攪拌培養でも実施できるが、深部通気
攪拌培養を行なうのが好ましい。
Cultivation can be carried out in a normal aqueous medium containing the above-mentioned culture medium by surface culture or deep aeration agitation culture, but deep aeration agitation culture is preferably carried out.

培養条件は。通常の通気条件下に、液性がpH8,5〜
11.5好ましくはpH4,5〜9,5及び培養温度1
5〜35℃好ましくは20〜32℃で通常3〜7日間で
有利に培養できる。
What are the culture conditions? Under normal aeration conditions, the liquid has a pH of 8.5~
11.5 Preferably pH 4.5 to 9.5 and culture temperature 1
Culture can be advantageously carried out at 5 to 35°C, preferably 20 to 32°C, usually for 3 to 7 days.

次いで上記培養後に培養液中に生産された上記化合物C
I)を採取する。
Next, the above compound C produced in the culture solution after the above culture
I) is collected.

採取法は特に制御限されず生産された化合物の理化学的
性状を利用した公知の各種方法がいずれも採用できる。
The collection method is not particularly limited, and any known method that utilizes the physical and chemical properties of the produced compound can be employed.

例えば不純物との溶解度の差、通常の吸着剤例えば活性
炭、XAD−2、シリカゲル、イオン交換樹脂、セファ
デックス等に対する吸着親和力の差、二液。
For example, differences in solubility with impurities, differences in adsorption affinity for common adsorbents such as activated carbon, XAD-2, silica gel, ion exchange resins, Sephadex, etc., two liquids.

相間の分配率の差等を利用する方法及び2等方法の組み
合せにより実施できる。
This can be carried out by a combination of a method that utilizes the difference in distribution ratio between phases, and a secondary method.

より具体的には、培養液を常法に従い濾過もしくは遠心
分離して予め菌体を除去する。
More specifically, the culture solution is filtered or centrifuged according to a conventional method to remove bacterial cells in advance.

次いで上澄液にメタノールを加え攪拌後2〜3時間放置
し、再度遠心分離によ・り沈殿物を除く。
Next, methanol is added to the supernatant, stirred, and left for 2 to 3 hours, and the precipitate is removed by centrifugation again.

更に同量の酢酸エチルで抽出後、溶媒を留去する。After further extraction with the same amount of ethyl acetate, the solvent was distilled off.

抽出物をメタノール中に投じメタノール溶液を活性炭カ
ラムに通じた後、溶出液の溶媒を留去する。
After pouring the extract into methanol and passing the methanol solution through an activated carbon column, the solvent of the eluate is distilled off.

残渣をセファデックスLH−20でゲル濾過し得られる
各画分を後述する抗補体活性試験に供し、活性な部分を
集め、之より溶媒を留去する。
The residue is gel-filtered with Sephadex LH-20, each fraction obtained is subjected to the anti-complement activity test described below, the active portion is collected, and the solvent is distilled off.

かくして上記式〔Dで示される目的の化合物を単離精製
できる。
In this way, the target compound represented by the above formula [D] can be isolated and purified.

得られた化合物は以下の理化学的性質を有し、上記犬山
で表わされる化合物であると同定される。
The obtained compound has the following physicochemical properties and is identified as the compound represented by Inuyama above.

1)旋光度 0 (ロ)D =48° (C=2.5.メタノール)2)
元素分析値 C23H3006 計算値(輪 C68,64,H7,51 実測イ直@ C68,58,H7,553)紫外線吸
収スペクトル(UV)分析 エタノール λmax =246nm(ε=16474)307n
m(ε=6659) 350nm (ε=5427) 4)核磁気共鳴スペクトル(NMR)分析ピリジン−d
5 (DSS)を溶媒とするNMR分析図を第2図に示
す。
1) Optical rotation 0 (b) D = 48° (C = 2.5. methanol) 2)
Elemental analysis value C23H3006 Calculated value (ring C68,64,H7,51 Actual measurement @ C68,58,H7,553) Ultraviolet absorption spectrum (UV) analysis Ethanol λmax = 246 nm (ε = 16474) 307n
m (ε=6659) 350 nm (ε=5427) 4) Nuclear magnetic resonance spectrum (NMR) analysis Pyridine-d
An NMR analysis diagram using 5 (DSS) as a solvent is shown in FIG.

また上記化合物〔I〕の抗補体活性は、「免疫化学」第
830〜834頁(朝食書店発行、山村雄−他編集、1
973年)に記載の試験法に従い測定及び確認される。
In addition, the anti-complement activity of the above compound [I] is shown in "Immunochemistry", pp. 830-834 (published by Chokoku Shoten, edited by Yu Yamamura et al., 1
973).

即ち試験管に上記化合物印の水溶液(pHキ8 ) 0
.5ml、 I X 10”セル/1111! (7)
感作血球(EA)0.5r/ll、等張ゼラチンを含む
ベロナール緩衝食塩水(GVB++)の1rILl及び
GVB”で150倍に希釈した補体薄情(g−p−C)
0、5 rnlを採取し、37℃で60分間保温後2に
氷冷した生理食塩水5mlを加えて遠心分離し、次いで
分離された上清の吸光度を吸光計0D413で測定し、
供給化合物印によって感作血球がどれ程その溶廂を抑制
されるかを求めることにより測定される。
That is, in a test tube, put an aqueous solution (pH: 8) of the compound marked above.
.. 5ml, I x 10” cell/1111! (7)
Sensitized hemocytes (EA) 0.5 r/l, complement sensitization (g-p-c) diluted 150 times with 1 r ILl of veronal buffered saline (GVB++) containing isotonic gelatin and GVB''.
After collecting 0 and 5 rnl and incubating at 37°C for 60 minutes, 5 ml of ice-cold physiological saline was added to 2 and centrifuged, and the absorbance of the separated supernatant was measured using an absorbance meter 0D413.
It is determined by determining how much the dissolution of sensitized blood cells is inhibited by the supplied compound mark.

上記方法に従い測定された吸光度及び抗補体活性値を下
記第1表に示す。
The absorbance and anti-complement activity values measured according to the above method are shown in Table 1 below.

尚上記第1表中ブランクは、化合物〔Dを採取すること
なく、GVB”及びEAのみを採取した試料、また対照
※はE A O,5mlと水2.0rnlとを採取した
100係溶而を示す試料である。
The blank in Table 1 above is a sample in which only the compound [GVB'' and EA was collected without collecting D, and the control* is a sample in which 5 ml of E A O and 2.0 rnl of water were collected. This is a sample that shows

そして抗補体活性値は、化合物CI)を採取した試料/
161の0D413値からブランク(試料/462及び
3)のOD4□3平均値を差し引いた値(OD’)を、
対照※(試料44及び5)の0D413平均値から同様
にブランクの0D413平均値を差し引いた値COD
’〕で除した値即ち溶匍比(ylにより求められる。
And the anti-complement activity value is calculated from the sample from which compound CI) was collected.
The value (OD') obtained by subtracting the OD4□3 average value of the blank (sample/462 and 3) from the 0D413 value of 161 is
Value COD obtained by subtracting the 0D413 average value of the blank from the 0D413 average value of the control* (Samples 44 and 5)
'], that is, the molten metal ratio (yl).

従って該溶鹿比(y)が1より小さくなれば抗補体活性
を有することとみなし得る。
Therefore, if the solubility ratio (y) is less than 1, it can be considered to have anti-complement activity.

抗補体活性は上記溶面比(y)の値が小さい程高いとい
え、化合物〔Dはこの試験結果より優れた抗補体活性を
有することが判る。
It can be said that the smaller the value of the above-mentioned solubility surface ratio (y), the higher the anti-complement activity, and it can be seen from the results of this test that Compound [D] has superior anti-complement activity.

以下不発明徴生物の土壌からの純粋分離法、該微生物の
継代培養による再現性につき実施例を挙げ詳述する。
Hereinafter, a method for pure isolation of non-inventive microorganisms from soil and reproducibility by subculturing the microorganisms will be described in detail with examples.

実施例 1 採取した土壌を滅菌生理食塩水で1000倍に希釈し、
その1rrLlと下記分離用寒天培地(1)の9rnl
とを混合し、滅菌シャーレ内に入れ、28℃にて5日間
培養する。
Example 1 The collected soil was diluted 1000 times with sterile physiological saline,
That 1rrLl and 9rnl of the following separation agar medium (1)
The cells were mixed together, placed in a sterile petri dish, and cultured at 28°C for 5 days.

分離用寒天培地(I) 組 成バレイショ浸
出液 200g ブドウ糖 21 寒天 15g 水 1000rrLlpH
キ5.6 上記培養により発生するコロニーを白金耳にて下記組成
の斜面寒天培地(mlに移し、28℃で3日間培養する
Agar medium for separation (I) Composition Potato infusion 200g Glucose 21 Agar 15g Water 1000rrLlpH
G5.6 Transfer the colonies generated by the above culture to a slanted agar medium (ml) having the following composition using a platinum loop, and culture at 28°C for 3 days.

斜面寒天培地(II) 組 成 麦芽エキス 205’ 酵母エキス 2g ペプトン 1g ブドウ糖 4g 寒 天 20.9 水 1000mg 上記培養により培地上に発生する菌の1白金耳を生理食
塩水で1oooo倍に希釈し、その1rnlを分離用寒
天培地(I)の9Mと混合し、滅菌シャーレ内で、28
℃で5日間培養し、出来た複数のコロニーが相互間に相
異しないことを肉眼的及び顕微鏡的に確認する。
Slanted agar medium (II) Composition Adult malt extract 205' Yeast extract 2g Peptone 1g Glucose 4g Agar 20.9 Water 1000mg One platinum loop of bacteria generated on the medium by the above culture was diluted 100 times with physiological saline, Mix 1rnl of it with 9M of isolation agar medium (I) and place it in a sterile petri dish for 28 hours.
Culture at ℃ for 5 days, and confirm visually and microscopically that the resulting colonies are not different from each other.

上記コロニーの内10個のコロニーを夫々斜面寒天培地
(n)に接種し、28℃で3日間培養し、10本の斜面
培地(I)上の菌が肉眼的及び顕微鏡的に同じ菌である
ことを確認し、また2等10本の培養菌についての各培
地上の性状及び生理学的性質が同一であることを確認し
た。
10 of the above colonies were inoculated onto slanted agar medium (n) and cultured at 28°C for 3 days, and the bacteria on the 10 slanted medium (I) were macroscopically and microscopically the same bacteria. This was confirmed, and it was also confirmed that the properties and physiological properties on each medium of the 10 second-class cultured bacteria were the same.

上記各培地上の性状及び生理学的性質は前述した通りで
ある。
The properties and physiological properties of each of the above-mentioned media are as described above.

上記試験の結果各10本の培養菌はすべて自然界より純
粋に分離された単−菌であることが判る。
As a result of the above test, it was found that all 10 cultured bacteria were monobacteria isolated from nature.

次いで上記で純粋培養された斜面寒天培地(n)上の菌
に、保護剤(スキムミルク10%及びグルタミン酸ナト
リウム1%の水溶液)を加え、斜面寒天培地(IIJ上
にて、胞子懸濁液を調整する。
Next, a protective agent (10% skim milk and 1% sodium glutamate aqueous solution) was added to the pure cultured bacteria on the slanted agar medium (n), and a spore suspension was prepared on the slanted agar medium (IIJ). do.

この胞子懸濁液を凍結乾燥用アンプルに約1mlずつ分
注し、凍結乾燥を行なう。
Approximately 1 ml of this spore suspension is dispensed into freeze-drying ampoules and freeze-dried.

該凍結乾燥は胞子懸濁液のはいったアンプルをドライア
イス−アセトン中にて急速凍結し、これを凍結乾燥機に
セットし、真空度が0.03トール以下とすることによ
り行なわれる。
The freeze-drying is carried out by quickly freezing the ampoule containing the spore suspension in dry ice-acetone, setting it in a freeze dryer, and setting the degree of vacuum to 0.03 torr or less.

次いでガスバーナーで真空溶封後4℃で保存する。Then, it is vacuum sealed with a gas burner and stored at 4°C.

かくして得られる凍結乾燥菌(標品)を、3ケ月保存後
、アンプルを開封し、滅菌ミニスパーチル−を用いて滅
菌試験管に移し、これに復水液(グルコース1%及び酵
母エキス1%の水溶液)を加え、1時間以上放置した後
、前記と同条件下に各培地上での性状及び生理学的性質
を調べた結果、凍結前の菌(標品)と変化は認められな
かった。
After storing the freeze-dried bacteria (standard sample) obtained in this way for 3 months, open the ampoule, transfer it to a sterile test tube using a sterile mini-spertil, and add condensate (an aqueous solution of 1% glucose and 1% yeast extract) to this. ) was added and allowed to stand for over 1 hour, and the properties and physiological properties were examined on each medium under the same conditions as above, and no changes were observed from the bacteria before freezing (standard sample).

また上記凍結及び再生を1ケ月毎に5度繰り返した菌に
つき同様に、各培地上での性状及び生理学的性質を調べ
た結果変化は認められなかった。
Furthermore, the properties and physiological properties of the bacteria on each culture medium were similarly examined after the above-mentioned freezing and regeneration was repeated five times every month, and no changes were observed.

このことより本発明徴生物は、継代培養によって確実に
同一結果を再現できることが判る。
This shows that the same results can be reliably reproduced by subculturing the symptomatic organisms of the present invention.

次いで本発明徴生物を利用して化合物CI)を製造した
例を参考例として挙げる。
Next, an example in which compound CI) was produced using the symptomatic organism of the present invention will be listed as a reference example.

参考例 1 上記実施例1において純粋培養したスタキボトリス エ
スピー、T−789、その凍結後の再生菌及び継代培養
菌の夫々を500d容坂ロフラスコに下記組成の培地1
00rnlを入れ、32℃、pH=7.5で4日間往復
振とう培養する。
Reference Example 1 Stachybotrys sp. T-789 pure cultured in Example 1 above, the regenerated bacteria after freezing, and the subcultured bacteria were each placed in a 500 d Sakaro flask in medium 1 with the following composition.
00rnl and cultured at 32°C and pH=7.5 for 4 days with reciprocal shaking.

グリセリン 0.5% ブドウ糖 1.2% コーンスチーブリ力− 0.5% 乾燥酵母 0.1係 麦芽エキス 0.2% Mg50
. 0.05% NaC1O,3% 前述で得られた種培養1本を301容、ジャーファメン
ターに201の上記組成の培地を入れ培。
Glycerin 0.5% Glucose 1.2% Corn Stable - 0.5% Dried yeast 0.1 malt extract 0.2% Mg50
.. 0.05% NaC1O, 3% Add 301 volumes of one bottle of the seed culture obtained above, and culture 201 volumes of the medium with the above composition in a jar fermenter.

養温度32℃、通気量11/l培地・分、攪拌数300
回転/分で5日間培養を行なった。
Cultivation temperature: 32°C, aeration rate: 11/l medium/min, number of stirring: 300
Culture was performed for 5 days at rotation/min.

得られた培養液を8000回転/回転速心分離し菌体を
除去し、この上澄液に51のメタノールを加え攪拌して
3時間放置したのち、遠心分離して沈殿物を除去し、等
量の酢酸エチルで抽出する。
The obtained culture solution was centrifuged at 8000 revolutions/rotation speed to remove bacterial cells, and methanol 51 was added to this supernatant, stirred and left for 3 hours, then centrifuged to remove the precipitate, etc. of ethyl acetate.

酢酸エチル層の溶媒を減圧下留去したのち、残渣をメタ
ノールに溶かし活性炭カラムを通過させたのち、溶出液
を減圧下濃縮乾固後、クロロホルム:酢酸エチルエステ
ル=1: 1 (V/V)に溶解させて、セファデック
スLH−20のカラムでゲル濾過し、薄層クロマトグラ
フィ(酢酸エチル−クロロホルム−酢酸−50:50:
2(V/V))でRf−〇、34に、また同様の薄層ク
ロマトグラフィ(ベンゼン−ブタノール−酢酸−60:
15:5(V/■))でRf=0.58に相当する抗補
体活性画分をとり、これより溶媒を留去することにより
、抗補体活性を有する淡黄色の弱酸性物質である6゜7
−シヒドロキシー2,5,5,8a−テトラメチル−1
,2,3,4,4a、5,6,7,8゜8a−デカヒド
ロナフタレン−1−スピロ−2′(6’、7′−ジホル
ミル−47−ヒドロキシ−2/、3/−ジヒドロベンゾ
フラン)を得た。
After the solvent in the ethyl acetate layer was distilled off under reduced pressure, the residue was dissolved in methanol and passed through an activated carbon column. The eluate was concentrated to dryness under reduced pressure, and then chloroform:ethyl acetate = 1: 1 (V/V) The solution was dissolved in ethyl acetate, gel filtrated with a column of Sephadex LH-20, and subjected to thin layer chromatography (ethyl acetate-chloroform-acetic acid-50:50:
2 (V/V)) to Rf-〇, 34, and similar thin layer chromatography (benzene-butanol-acetic acid-60:
By taking the anti-complement activity fraction corresponding to Rf=0.58 (15:5 (V/■)) and distilling off the solvent, a pale yellow weakly acidic substance with anti-complement activity is obtained. There is 6゜7
-cyhydroxy-2,5,5,8a-tetramethyl-1
,2,3,4,4a,5,6,7,8゜8a-decahydronaphthalene-1-spiro-2'(6',7'-diformyl-47-hydroxy-2/,3/-dihydrobenzofuran ) was obtained.

この化合物の理化学的性質は前述の通りであった。The physicochemical properties of this compound were as described above.

この参考例から本発明徴生物の抗補体活性物質生産能に
ついても充分にその再現性のあることが明らかである。
From this reference example, it is clear that the ability of the organism of the present invention to produce an anti-complement active substance is sufficiently reproducible.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の微生物であるスタキボトリスエスピー
、T−789の顕微鏡写真を示す。 第2図は本発明徴生物の産出する抗補体活性物質である
6、7−シヒドロキシー2,5,5,8a−テトラメチ
ル−1,2,3,4,4a、5,6,7゜8.8a−デ
カヒドロナフタレン−1−スピロ−2/ (6/、7
/−ジホルミル−47−ヒドロキシ2/、3/−ジヒド
ロベンゾフラン)の核磁気共鳴スペクトル分析図を示す
FIG. 1 shows a micrograph of Stachybotrys sp. T-789, which is the microorganism of the present invention. Figure 2 shows the anti-complement active substance 6,7-hydroxy-2,5,5,8a-tetramethyl-1,2,3,4,4a,5,6,7° produced by the organism of the present invention. 8.8a-decahydronaphthalene-1-spiro-2/ (6/, 7
FIG. 2 shows a nuclear magnetic resonance spectrum analysis diagram of 2/-diformyl-47-hydroxy 2/, 3/-dihydrobenzofuran).

Claims (1)

【特許請求の範囲】[Claims] 1 スタキポトリス属に属し、梗子柄が単純分枝をなし
、ツアペック寒天培地で良好な梗子胞子形成を認め、至
適生育pHが4.5〜10.5の範囲にある微工研菌寄
第3802号として寄託されたスタキボトリス エスピ
ー T−789株。
1 Belonging to the genus Stachypotrys, the pedicel is simply branched, good spore formation is observed on Czapek agar medium, and the optimum growth pH is in the range of 4.5 to 10.5. Stachybotrys sp. strain T-789 deposited as No.
JP14512481A 1981-09-14 1981-09-14 Novel microorganism Expired JPS5822193B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14512481A JPS5822193B2 (en) 1981-09-14 1981-09-14 Novel microorganism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14512481A JPS5822193B2 (en) 1981-09-14 1981-09-14 Novel microorganism

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP15895977A Division JPS5492680A (en) 1977-06-30 1977-12-29 Novel microorganism

Publications (2)

Publication Number Publication Date
JPS5783281A JPS5783281A (en) 1982-05-25
JPS5822193B2 true JPS5822193B2 (en) 1983-05-07

Family

ID=15377949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14512481A Expired JPS5822193B2 (en) 1981-09-14 1981-09-14 Novel microorganism

Country Status (1)

Country Link
JP (1) JPS5822193B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366986A (en) * 1988-04-15 1994-11-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity
US5173499A (en) * 1988-04-15 1992-12-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity

Also Published As

Publication number Publication date
JPS5783281A (en) 1982-05-25

Similar Documents

Publication Publication Date Title
JPH02231071A (en) Microbiological preparation of immunosuppressive antibiotic
US2803586A (en) ph control in production of fumagillin
JPS5822193B2 (en) Novel microorganism
US3224945A (en) Process for the production of ergot alkaloids
US2652356A (en) Fumagillin and preparation
US3616237A (en) Method of preparing thiogriseofulvins
US3467579A (en) Microbiological process for the production of lycopene
JPS61176531A (en) Novel substance kt5556 and preparation thereof
JPS5822194B2 (en) Novel microorganism
JPH03227971A (en) Carbazole compound
JPH05170769A (en) New compound q-11270 or its production
JPS6015318B2 (en) New antibiotic SF-1942 substance, its manufacturing method and anticancer agent containing it
JPH01193284A (en) Physiologically active substance pi-08s
JPS5824118B2 (en) Shinko Seibutsushitsu SF-1540 Shinko Seibutsushitsuhou
KR810000686B1 (en) Process for the preparation of piperidine derivative
US3532714A (en) Antifungal agents
JP2933451B2 (en) New microorganism and method for producing red pigment by new microorganism
US3310468A (en) Antifungal antibiotic rutamycin and process for the production thereof
JPH0341089A (en) Physiologically active substance 3127
JPS6119494A (en) Novel physiologically active substance ss33410 and its preparation
JPS62186787A (en) Novel microorganism
JPH0196189A (en) Novel antibiotic sf2446a2 substance, sf2446a3 substance, sf2446 b1 substance, sf2446b2 substance and sf2446b3 substance
JPS6027390A (en) Fr-900216 substance and its preparation
JPS6135788A (en) Physiologically active substance ss20846a and its preparation
JPS589677B2 (en) Novel bicyclodecadiene compound and its production method